Akoya Biosciences, Inc.

NASDAQ:AKYA

1.27 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -55.365-63.323-70.641-42.935-16.706-14.751
Depreciation & Amortization 7.6548.897.1494.7923.8153.055
Deferred Income Tax 0.004-0.0510.035-0.1550.0070.156
Stock Based Compensation 9.30610.4377.434.0390.4770.153
Change In Working Capital 0-14.4782.164-4.5612.394-1.377
Accounts Receivables 2.3-7.265-0.285-2.9746.697-3.373
Inventory -9.859-6.332-5.374-4.628-0.684-4.007
Accounts Payables -3.0171.1481.1934.361-3.045-0.049
Other Working Capital 0-2.0296.63-1.32-0.5746.052
Other Non Cash Items -5.7027.6260.3672.7523.17-1.012
Operating Cash Flow -44.103-50.899-53.496-36.068-6.843-13.776
Investing Activities:
Investments In Property Plant And Equipment -2.456-3.653-7.36-5.094-3.295-2.869
Acquisitions Net 000.05500.1450
Purchases Of Investments -104.2930-40.7740-0.145-10
Sales Maturities Of Investments 82.698734010.1680
Other Investing Activites 00-6.7190-0.145-0.023
Investing Cash Flow -24.0513.347-14.079-5.0946.728-12.892
Financing Activities:
Debt Repayment -1.02210.57430.629-0.3229.7854.959
Common Stock Issued 047.9670.447138.5530.12224.828
Common Stock Repurchased 000000
Dividends Paid 000-1.43500
Other Financing Activities -2.183-1.697-1.9030.239-4.29948.426
Financing Cash Flow -3.20556.84428.726137.0355.48628.561
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -71.3599.292-38.84995.8735.3711.893
Cash At End Of Period 12.46583.82474.532113.38117.50812.137